Literature DB >> 25626601

Polymorphisms of HLA-A, -B, -Cw and DRB1 antigens in Moroccan patients with ankylosing spondylitis and a comparison of clinical features with frequencies of HLA-B*27.

I El Mouraghi1, A Ouarour, I Ghozlani, E Collantes, R Solana, A El Maghraoui.   

Abstract

Ankylosing spondylitis (AS) is very often associated with human leukocyte antigen (HLA), particularly HLA-B*27. However, the strength of this association and clinical features may vary in different ethnic groups. Our study aims to assess the distribution of HLA-A, -B, -Cw and DRB1 alleles in Moroccan patients with AS and to compare the clinical features of AS and the frequencies of HLA-B27 in patients from Morocco with other series. Seventy-five patients diagnosed with AS and assessed for clinical manifestations were selected and compared to 100 healthy controls. HLA class I and II antigens were typed by polymerase chain reaction sequence-specific oligonucleotide. HLA-B27 subtypes were studied by polymerase chain reaction amplification with sequence-specific primers. HLA-B27 was found in 64% of patients. It was positively associated with younger age at disease onset, family history, and uveitis while it had a negative association with late onset. Six B*27 subtypes were identified in the AS group. HLA-B*2705 and B*2702 were the most common observed subtypes. Among other HLA genes, a significant increase in the prevalence of HLA-Cw*02 and HLA-DRB*15 was found in AS patients. HLA-B27 is involved in the predisposition of AS in the Moroccan population. HLA-B*2705 and B*2702 were the predominant subtypes supporting previous reports in Caucasian spondyloarthropathies. Other HLA genes, HLA-Cw*02 and HLA-DRB1*15, seem to confer predisposing effect to the disease. However, the lower frequency of HLA-B27 compared to the literature in our study suggests the existence of different genetic and/or environmental factors in Morocco.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HLA polymorphism; HLA-B27 subtypes; Moroccan population; ankylosing spondylitis; clinical features

Mesh:

Substances:

Year:  2015        PMID: 25626601     DOI: 10.1111/tan.12515

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  7 in total

Review 1.  Spondyloarthritis in North Africa: an update.

Authors:  Samy Slimani; Wafa Hamdi; Kawtar Nassar; Asgar Ali Kalla
Journal:  Clin Rheumatol       Date:  2021-02-09       Impact factor: 2.980

Review 2.  Indirect comparisons of the efficacy of biological agents in patients with active ankylosing spondylitis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Patricia J Erwin; Matthew J Koster
Journal:  Clin Rheumatol       Date:  2017-05-28       Impact factor: 2.980

Review 3.  Ankylosing Spondylitis.

Authors:  Nazanin Ebrahimiadib; Sahar Berijani; Mohammadreza Ghahari; Fatemeh Golsoorat Pahlaviani
Journal:  J Ophthalmic Vis Res       Date:  2021-07-29

4.  HLA class I and II alleles in susceptibility to ankylosing spondylitis.

Authors:  John D Reveille; Xiaodong Zhou; MinJae Lee; Michael H Weisman; Lin Yi; Lianne S Gensler; Hejian Zou; Michael M Ward; Mariko L Ishimori; Thomas J Learch; Dongyi He; Mohammad H Rahbar; Jiucun Wang; Matthew A Brown
Journal:  Ann Rheum Dis       Date:  2018-10-19       Impact factor: 19.103

Review 5.  HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications.

Authors:  Robert Busch; Simon Kollnberger; Elizabeth D Mellins
Journal:  Nat Rev Rheumatol       Date:  2019-06       Impact factor: 20.543

6.  A genomic study on distribution of human leukocyte antigen (HLA)-A and HLA-B alleles in Lak population of Iran.

Authors:  Farhad Shahsavar; Ali-Mohammad Varzi; Seyyed Amir Yasin Ahmadi
Journal:  Genom Data       Date:  2016-11-10

Review 7.  Rheumatic diseases in Africa.

Authors:  Olufemi Adelowo; Girish M Mody; Mohammed Tikly; Omondi Oyoo; Samy Slimani
Journal:  Nat Rev Rheumatol       Date:  2021-04-13       Impact factor: 20.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.